Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report

被引:8
作者
Tiseo, Marcello [1 ]
Gelsomino, Francesco [1 ]
Bartolotti, Marco [1 ]
Barili, Matteo Pesenti [2 ]
Ardizzoni, Andrea [1 ]
机构
[1] Univ Hosp Parma, Med Oncol Unit, I-43100 Parma, Italy
[2] Univ Hosp Parma, Radiol Unit, I-43100 Parma, Italy
关键词
Typhlitis; Pemetrexed; Non-small cell lung cancer; Second line; Chemotherapy; Neutropenia; NEUTROPENIC ENTEROCOLITIS; PHASE-III; ADULTS; CISPLATIN; DOCETAXEL; THERAPY;
D O I
10.1016/j.lungcan.2009.02.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neutropenic enterocolitis, or typhlitis, is an unusual acute complication of chemotherapy-induced neutropenia, characterized by inflammatory process involving colon and/or small bowel that may progress to necrosis, haemorrhage, perforation and septicaemia. Typhlitis is usually seen in the setting of severe chemotherapy-induced neutropenia for acute leukaemia. Nevertheless, it is increasingly recognized as a complication of therapy in solid tumors. We present a case of typhlitis in a patient with advanced non-small cell lung cancer (NSCLC) who received pemetrexed, as second-line chemotherapy treatment. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:251 / 253
页数:3
相关论文
共 18 条
[1]  
Bagnoli P, 2007, TUMORI, V93, P608
[2]   Neutropenic enterocolitis in adults: Case series and review of the literature [J].
Cunningham, SC ;
Fakhry, K ;
Bass, BL ;
Napolitano, LM .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) :215-220
[3]   Neutropenic enterocolitis (typhi litis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature [J].
D'Amato, G ;
Lima, CR ;
Mahany, JJ ;
Muro-Cacho, C ;
Haura, EB .
LUNG CANCER, 2004, 44 (03) :381-390
[4]   Neutropenic enterocolitis [J].
Davila M.L. .
Current Treatment Options in Gastroenterology, 2006, 9 (3) :249-255
[5]   Neutropenic enterocolitis: Current issues in diagnosis and management [J].
Davila M.L. .
Current Infectious Disease Reports, 2007, 9 (2) :116-120
[6]  
ETTINGHAUSEN SE, 1993, SURG CLIN N AM, V73, P993
[7]   Neutropenic enterocolitis in adults:: systematic analysis of evidence quality [J].
Gorschlüter, M ;
Mey, U ;
Strehl, J ;
Ziske, C ;
Schepke, M ;
Schmidt-Wolf, IGH ;
Sauerbruch, T ;
Glasmacher, A .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (01) :1-13
[8]   Second-line treatment of advanced non-small cell lung cancer [J].
Gridelli, Cesare ;
Ardizzoni, Andrea ;
Ciardiello, Fortunato ;
Hanna, Nasser ;
Heymach, John V. ;
Perrone, Francesco ;
Rosell, Rafael ;
Shepherd, Frances A. ;
Thatcher, Nick ;
Vansteenkiste, Johan ;
De Petris, Luigi ;
Di Maio, Massimo ;
De Marinis, Filippo .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) :430-440
[9]   Pemetrexed disodium: A novel Antifolate clinically active against multiple solid tumors [J].
Hanauske, AR ;
Chen, V ;
Paoletti, P ;
Niyikiza, C .
ONCOLOGIST, 2001, 6 (04) :363-373
[10]   Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].
Hanna, N ;
Shepherd, FA ;
Fossella, FV ;
Pereira, JR ;
De Marinis, F ;
von Pawel, J ;
Gatzemeier, U ;
Tsao, TCY ;
Pless, M ;
Muller, T ;
Lim, HL ;
Desch, C ;
Szondy, K ;
Gervais, R ;
Shaharyar ;
Manegold, C ;
Paul, S ;
Paoletti, P ;
Einhorn, L ;
Bunn, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597